European Journal of Cancer
Volume 43, Issue 1 , Pages 53-54, January 2007

A phase II study for the evaluation of quinine as a modulator of multidrug resistance in non-Hodgkin’s lymphoma

  • Pierre Soubeyran

      Affiliations

    • Département de Médecine, Institut Bergonié, Bordeaux, France
    • ,
  • Amine Masmoudi

      Affiliations

    • Département de Médecine, Institut Bergonié, Bordeaux, France
    • ,
  • Christelle Blanc-Bisson

      Affiliations

    • Département de Médecine, Institut Bergonié, Bordeaux, France
    • ,
  • Ricardo Bellott

      Affiliations

    • Laboratoire de Pharmacologie des Agents Anticancéreux, Institut Bergonié, Université Victor Segalen Bordeaux 2, Bordeaux, France
    • ,
  • Isabelle Soubeyran

      Affiliations

    • Laboratoire d’Anatomie Pathologique, Institut Bergonié, Bordeaux, France
    • ,
  • Catherine Donamaria

      Affiliations

    • Département de Pharmacie, Institut Bergonié, Bordeaux, France
    • ,
  • Matthieu Molimard

      Affiliations

    • Laboratoire de Pharmacologie, Université Victor Segalen Bordeaux 2, Bordeaux, France
    • ,
  • Nathalie Quénel

      Affiliations

    • Département de Médecine, Institut Bergonié, Bordeaux, France
    • ,
  • Bernard Hœrni

      Affiliations

    • Département de Médecine, Institut Bergonié, Bordeaux, France
    • ,
  • Jacques Robert

      Affiliations

    • Laboratoire de Pharmacologie des Agents Anticancéreux, Institut Bergonié, Université Victor Segalen Bordeaux 2, Bordeaux, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 556 333 327; fax: +33 556 333 389.

Received 20 November 2005; accepted 24 November 2005.

Keywords: Epirubicin, Multidrug resistance reversal, Non-Hodgkin’s lymphoma, P-glycoprotein, Quinine

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(06)00392-3

doi:10.1016/j.ejca.2005.11.044

European Journal of Cancer
Volume 43, Issue 1 , Pages 53-54, January 2007

Article Tools